Suppr超能文献

一项比较氯普唑仑和硝西泮催眠疗效的多中心医院研究。

A multicentre hospital study to compare the hypnotic efficacy of loprazolam and nitrazepam.

作者信息

McAlpine C J, Ankier S I, Elliott C S

出版信息

J Int Med Res. 1984;12(4):229-37. doi: 10.1177/030006058401200402.

Abstract

A multicentre, parallel group hospital study was carried out in 190 subjects with insomnia to compare the efficacy, incidence of hangover and the side-effects of loprazolam and nitrazepam. Following 2 nights single-blind phase on placebo, loprazolam (1.0 mg), nitrazepam (5.0 mg) or placebo was administered double-blind for 7 consecutive nights. Visual analogue scales and questions were used to rate efficacy. There was no statistically significant difference between loprazolam and nitrazepam for 'ease of getting to sleep', 'restfulness of sleep' and 'depth of sleep'. Like nitrazepam, loprazolam diminished the number of periods of wakefulness and made it 'easier to get to sleep again'. Subjective evaluation showed that hangover was not a feature of loprazolam. It did not affect morning alertness and patients thought they had improved balance and co-ordination while on this drug. These findings are in keeping with the evidence of other workers who have shown only minimal psychomotor impairment, if any, with loprazolam (1.0 mg). There was no statistically significant difference between treatments with respect to frequency or incidence of side-effects.

摘要

一项针对190名失眠患者的多中心平行组医院研究开展,以比较氯普唑仑和硝西泮的疗效、宿醉发生率及副作用。在安慰剂单盲期2晚后,氯普唑仑(1.0毫克)、硝西泮(5.0毫克)或安慰剂双盲给药连续7晚。使用视觉模拟量表和问题对疗效进行评分。氯普唑仑和硝西泮在“入睡难易程度”“睡眠安稳程度”和“睡眠深度”方面无统计学显著差异。与硝西泮一样,氯普唑仑减少了觉醒次数,且“再次入睡更容易”。主观评估显示,氯普唑仑不存在宿醉情况。它不影响早晨的警觉性,患者认为服用此药时平衡和协调能力有所改善。这些发现与其他研究人员的证据一致,他们表明氯普唑仑(1.0毫克)即便有精神运动损害,也极为轻微。治疗在副作用发生频率或发生率方面无统计学显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验